Medical Microbiology articles for Germany

Time frame: 1 July 2025 - 30 June 2026

View topic

Count: 103

Article ‘Count’ for Medical Microbiology.

Journal Count Share
1 0.05
Inactivating SARS-CoV-2 Virus with MOF-Composites as Smart Face Masks 0.05
1 1.00
Single-Cell Hyperthermia: Diamond Quantum Thermometry Reveals Thermal Control of Macrophage Polarization 1.00
2 0.57
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum 0.04
A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum 0.53
1 0.33
Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis 0.33
2 0.30
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 0.23
Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection 0.07
6 0.61
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection 0.38
<atl>Trends in Antifungal Resistance and Mechanistic Insights Into Azole Resistance in iCandida (candidozyma) auris/i : A 13-Year Study of a Comprehensive Set of Clinical Isolates From India</atl> 0.02
Predictors of Treatment Failure in Children Living With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial 0.04
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials 0.07
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years 0.05
Respiratory Syncytial Virus After CAR T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort 0.05
4 1.46
Functional anti-preS1 antibody responses associated with viral control in chronic hepatitis B 0.07
Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortia 0.47
Nucleotide analogue bemnifosbuvir inhibits hepatitis E virus replication in preclinical models 0.76
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.16
1 0.05
IL1β Signaling Mediates the Interaction Between Hepatitis B and C Viruses. 0.05
6 0.59
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares 0.06
144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial 0.28
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort 0.12
A phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C 0.08
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program 0.02
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells 0.03
10 2.77
Identification of host gene transcripts by machine learning and their application to predict outcome in Ebola virus disease 0.17
Nosocomial outbreak of Lassa fever in Conakry, Guinea, 2022 0.31
Viral Dynamics of the Respiratory Syncytial Virus During Experimental Human Challenge: Implication for Transmission and Protection 0.29
Age-Specific Concentrations and Seroprevalence of Antibodies Against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) Across 3 Sites in Kenya 0.04
Transient interferon-driven NK cell activation in acute hepatitis C 0.64
Presence of Lassa Virus RNA in Cerebrospinal Fluid Indicating Neuroinvasive Lassa Fever in Pediatric Patients From Edo State, Nigeria 0.26
Efficacy of praziquantel for treatment of Plasmodium falciparum infection in asymptomatic Gabonese adults: A double-blind placebo-controlled randomized phase IIb clinical trial 0.67
Leptospirosis Prevalence and Risk Factors Among Patients Presenting With Fever to 4 Healthcare Sites in Sub-Saharan Africa and South East Asia: An International Multisite Observational and Nested Case–Control Study 0.03
Epstein-Barr Virus Antibody Response Patterns in Endemic and Non-Endemic Cases of Nasopharyngeal Carcinoma 0.27
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS) 0.10
1 0.92
Targeting the SARS-CoV-2 RNA Translation Initiation Element SL1 by Molecules of Low Molecular Weight 0.92
1 1.00
Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis 1.00
1 0.71
Silver-Loaded Titania-Based Metal–Organic Frameworks as a Platform for Silver Ion Release for Antibacterial Applications 0.71
5 1.93
Host control of persistent Epstein–Barr virus infection 0.03
Transmission of MPXV from fire-footed rope squirrels to sooty mangabeys 0.65
Population-scale sequencing resolves determinants of persistent EBV DNA 0.05
EBV induces CNS homing of B cells attracting inflammatory T cells 0.35
Non-antibiotics disrupt colonization resistance against enteropathogens 0.86
1 0.06
Machine learning enables scalable and systematic hierarchical virus taxonomy 0.06
32 11.56
Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda 0.08
Highly efficient anogenital transmission of clade Ia monkeypox virus associated with increased shedding 0.06
A structurally unique effector shared between vascular wilt fungi drives cotton and olive defoliation 0.12
Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing 0.22
Human angiotensin‑converting enzyme 2‑specific benzothiazole-based allosteric inhibitor against pan‑sarbecoviruses 0.04
Stress-induced ribosome degradation in is mediated by the RNase Y-specificity complex 1.00
HBV HBx protein masks epigenetic reader Spindlin1 via an inter-molecular zinc finger to subvert transcriptional control 1.00
Human milk oligosaccharide mediates mutualism between Escherichia coli and Bifidobacterium bifidum 0.10
Potent acridone antimalarial against all three life stages of Plasmodium 0.03
Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis 0.05
B cell immunity to the Lassa virus glycoprotein is a correlate of vaccination-induced virus control in mice 0.12
Robust antibiotic sensitization of pathogenic Pseudomonas aeruginosa via negative hysteresis in the cell envelope 0.90
Major human schistosome species express different glycans with immunological and diagnostic implications 0.05
’s lifestyle includes soil-dwelling colonization of decaying plant material and airborne spread 0.63
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum 0.38
Cryo-electron tomography reveals coupled flavivirus replication, budding and maturation 0.06
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults 0.78
Sulfur-containing class of broad-spectrum antivirals improves influenza virus vaccine development 0.02
A metabolism-chromatin axis promotes differential ribosomal RNA transcription in the human malaria parasite 0.25
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease 0.30
Machine learning-supported framework for the classification of mpox infection and MVA immunization from multiplexed serology data 1.00
Conformational plasticity across phylogenetic clusters of RND multidrug efflux pumps and its impact on substrate specificity 0.67
High-resolution proteomics unveils salivary gland disruption and saliva-hemolymph protein exchange in Plasmodium-infected mosquitoes 0.10
CarbaDetector: a machine learning model for detecting carbapenemase-producing Enterobacterales from disk diffusion tests 0.52
Continuous exchange of an inner-membrane ring component is required for assembly and function of the type III secretion system 0.92
An RNA sponge directs the transition from feast to famine in Caulobacter crescentus 1.00
Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis 0.07
Thermodynamic dissipation constrains metabolic versatility of unicellular growth 0.50
Structural insights into proprotein convertase activation facilitate the engineering of highly specific furin inhibitors 0.25
Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1-specific antibody titers 0.22
Disruption of the ATP-dependent unfoldase ClpX reverses antifungal resistance in Cryptococcus neoformans 0.10
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.03
1 0.91
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models 0.91
1 0.48
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial 0.48
2 0.52
Phenotypic heterogeneity optimizes trade-offs during adaptive deployment of the type VI secretion system 0.40
Expansion of the functional genomics GRACE library reveals genes relevant for temperature-dependent fitness in Candida albicans. 0.12
1 0.06
Extreme-Temperature Single-Particle Heat Engine 0.06
7 3.71
Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30 0.94
A 3’UTR-derived small RNA modulates the life cycle of the cholera toxin–encoding filamentous phage, CTXϕ 0.80
Type I interferons induced upon respiratory viral infection impair lung metastatic initiation 0.10
Cryo-EM structure of locked spike glycoprotein from bat SARS-like coronavirus WIV1, molecular dynamics and biophysics across host range 0.45
SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting 0.20
The subcellular architecture of Paratrypanosoma confusum revealed by CryoET: A window into early trypanosome evolution 0.60
Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development 0.61
6 3.19
Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravir 0.10
Respiratory syncytial viral load drives ciliated cell dedifferentiation and suppresses antiviral immunity 1.00
Plant-associated fungi co-opt ancient antimicrobials for host manipulation 1.00
Hepatitis E virus replication is maintained in proliferative cells within the intestinal crypt 0.83
Structures of Vibrio cholerae transcription complexes reveal how ToxR and TcpP recruit the RNA polymerase and activate virulence genes 0.21
Glutamate utilization fuels rapid production of mitochondrial ROS in dendritic cells and drives systemic inflammation during tularemia 0.03
1 0.03
The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria 0.03
1 0.11
The Plasmodium CSP repeats have elastic properties with a critical role in sporozoite motility 0.11
2 1.13
Resistance variation and bacterial interactions shape adaptation of a genetically diverse pathogen population to antibiotic therapy 0.95
Unusual cell surfaces, pili, and archaella of iThermoplasmatales/i archaea 0.18
4 0.35
WHO estimates of the global, regional, and national foodborne burdens of 14 invasive parasitic diseases, 2000–21: an updated data synthesis 0.02
Characterising progression and regression patterns across the spectrum of tuberculosis: a multistate modelling approach 0.24
Pakistan on the Road to Zero Leprosy, an analysis of routine data for the period 1980–2022: a retrospective cohort study 0.07
The impact and cost-effectiveness of pulse oximetry and oxygen on acute lower respiratory infection outcomes in children in Malawi: a modelling study 0.02
2 0.11
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection 0.02
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D 0.09

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.